Test Catalog

Controlled Substance Identification

Test Code: D01

The D.01 Controlled Substance Identification assay is a combination colorimetric and GC-MS assays for qualitative identification of substances in seized evidence. The assay determines qualitative presence of >140 verified analytes comprising controlled substances, controlled substance analogs, prescription medications with potential for abuse, and common cutting agents.

Analytes Tested

  • ∆8-THC
  • ∆9-THC
  • 4-ANPP
  • 4F-MDMB-BUTINACA
  • 5F-MDMB-PINACA
  • 6-Acetylmorphine
  • AB-FUBINACA
  • Acetaminophen
  • Acetyl fentanyl
  • Acryl fentanyl
  • ADB-FUBINACA
  • ADB-PINACA
  • Adinazolam
  • AH-7921
  • Alfentanil
  • Alprazolam
  • Amobarbital
  • Amphetamine
  • α-PiHP
  • α-PPP
  • α-PVP
  • Baclofen
  • Bromazepam
  • Brorphine
  • Buprenorphine
  • Butalbital
  • Butorphanol
  • Butyryl fentanyl/Isobutyryl fentanyl
  • Butylone
  • BZP
  • Caffeine
  • Carbamazepine
  • Carfentanil
  • Carisoprodol
  • Cathinone
  • Chlordiazepoxide
  • Chlorpheniramine
  • cis-3-Methyl fentanyl
  • Clobazam
  • Clonazepam
  • Clonazolam
  • Cocaine
  • Codeine
  • Cotinine
  • Cyclobenzaprine
  • Cyclopropyl fentanyl
  • Delorazepam
  • Dextromethorphan
  • Dextrophan
  • Diazepam
  • Dibutylone
  • Diclazepam
  • Diphenhydramine
  • Doxylamine
  • Estazolam
  • Etizolam
  • Eutylone
  • Fentanyl
  • Flualprazolam
  • Flubromazepam
  • Flubromazolam
  • Flunitrazepam
  • Flurazepam
  • Furanyl fentanyl
  • Gabapentin
  • Guanfacine
  • Hydrocodone
  • Hydromorphone
  • Hydroxyzine
  • Ibuprofen
  • Isotonitazene
  • Ketamine
  • Levamisole
  • Loperamide
  • Lorazepam
  • LSD
  • mCPP
  • MDA
  • MDEA
  • MDMA
  • MDMB-4en-PINACA
  • Meclonazepam
  • Meperidine
  • Mephedrone
  • Meprobamate
  • Mescaline
  • Methadone
  • Methamphetamine
  • Methcathinone
  • Methocarbamol
  • Methylone
  • Methylphenidate
  • Midazolam
  • Mitragynine
  • MMB-FUBINACA
  • Morphine
  • MT-45
  • Naloxone
  • Naltrexone
  • Naproxen
  • N-ethyl pentylone
  • Nicotine
  • Nifoxipam
  • Nordiazepam
  • Norketamine
  • o/p-Fluorofentanyl
  • Ocfentanil
  • Orphenadrine
  • Oxazepam
  • Oxcarbazepine
  • Oxycodone
  • Oxymorphone
  • PCP
  • Pentobarbital
  • p-Fluorobutyryl fentanyl
  • Phenacetin
  • Phenazepam
  • Pheniramine
  • Phenobarbital
  • Phentermine
  • Phenytoin
  • p-Methoxybutyryl fentanyl
  • Pregabalin
  • Promethazine
  • Pseudoephedrine
  • Pyrazolam
  • Pyrovalerone
  • Remifentanil
  • Salicylic Acid
  • Secobarbital
  • Sufentanil
  • Tapentadol
  • Temazepam
  • TFMPP
  • Tramadol
  • Triazolam
  • U-47700
  • Valeryl fentanyl
  • Varenicline
  • Xylazine
  • Zaleplon
  • Zolazepam
  • Zolpidem

Methodology

Gas Chromatography coupled to mass spectrometry detection with library matching (GC-MS).

Assay Availability

Mon-Fri.

Results Reported

Typically, for positive, quantitative reports ≤ 8 business days TAT from receipt.

Acceptable Matrices

Liquids, powders, solids, plants, residue, and residue from paraphernalia. Any non-retrievable sample is considered.

Storage

Stored at RT until testing is completed. Long term storage of samples is 1 year.

Causes for Rejection

  • Identifiers on the specimen DO NOT match, when compared with the requisition.
  • Specimen handling has compromised the integrity of the specimen.
  • Specimen quality is compromised or beyond ability to complete testing and provide accurate results (i.e., quality not sufficient [QNS]).

Laboratory Contact

For further information, please call the MolecularDx Laboratory at 814-361-6997 or email info@molecdx.com.

Contact Us
MolecularDX uses Google Analytics to track basic website statistical information. You may opt out if you want. Opt out now.